Global and United States Clinical Biomarkers Market Report & Forecast 2022-2028

SKU ID :QYR-20827546 | Published Date: 03-May-2022 | No. of pages: 99
1 Study Coverage 1.1 Clinical Biomarkers Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Introduction 1.2 Global Clinical Biomarkers Outlook 2017 VS 2022 VS 2028 1.2.1 Global Clinical Biomarkers Market Size for the Year 2017-2028 1.2.2 Global Clinical Biomarkers Market Size for the Year 2017-2028 1.3 Clinical Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Clinical Biomarkers in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Clinical Biomarkers Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Clinical Biomarkers Market Dynamics 1.4.1 Clinical Biomarkers Industry Trends 1.4.2 Clinical Biomarkers Market Drivers 1.4.3 Clinical Biomarkers Market Challenges 1.4.4 Clinical Biomarkers Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Clinical Biomarkers by Type 2.1 Clinical Biomarkers Market Segment by Type 2.1.1 Diagnostic Biomarkers 2.1.2 Predictive Biomarkers 2.1.3 Prognostic Biomarkers 2.2 Global Clinical Biomarkers Market Size by Type (2017, 2022 & 2028) 2.3 Global Clinical Biomarkers Market Size by Type (2017-2028) 2.4 United States Clinical Biomarkers Market Size by Type (2017, 2022 & 2028) 2.5 United States Clinical Biomarkers Market Size by Type (2017-2028) 3 Clinical Biomarkers by Application 3.1 Clinical Biomarkers Market Segment by Application 3.1.1 Research and Academic Laboratories 3.1.2 Biopharmaceutical and Biotech Companies 3.1.3 Diagnostic Centers 3.1.4 Others 3.2 Global Clinical Biomarkers Market Size by Application (2017, 2022 & 2028) 3.3 Global Clinical Biomarkers Market Size by Application (2017-2028) 3.4 United States Clinical Biomarkers Market Size by Application (2017, 2022 & 2028) 3.5 United States Clinical Biomarkers Market Size by Application (2017-2028) 4 Global Clinical Biomarkers Competitor Landscape by Company 4.1 Global Clinical Biomarkers Market Size by Company 4.1.1 Top Global Clinical Biomarkers Companies Ranked by Revenue (2021) 4.1.2 Global Clinical Biomarkers Revenue by Player (2017-2022) 4.2 Global Clinical Biomarkers Concentration Ratio (CR) 4.2.1 Clinical Biomarkers Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Clinical Biomarkers in 2021 4.2.3 Global Clinical Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Clinical Biomarkers Headquarters, Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Type 4.3.1 Global Clinical Biomarkers Headquarters and Area Served 4.3.2 Global Clinical Biomarkers Companies Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Clinical Biomarkers Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Clinical Biomarkers Market Size by Company 4.5.1 Top Clinical Biomarkers Players in United States, Ranked by Revenue (2021) 4.5.2 United States Clinical Biomarkers Revenue by Players (2020, 2021 & 2022) 5 Global Clinical Biomarkers Market Size by Region 5.1 Global Clinical Biomarkers Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Clinical Biomarkers Market Size by Region (2017-2028) 5.2.1 Global Clinical Biomarkers Market Size by Region: 2017-2022 5.2.2 Global Clinical Biomarkers Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Clinical Biomarkers Market Size YoY Growth 2017-2028 6.1.2 North America Clinical Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 United States 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Clinical Biomarkers Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Clinical Biomarkers Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 China Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.3 Europe 6.3.1 Europe Clinical Biomarkers Market Size YoY Growth 2017-2028 6.3.2 Europe Clinical Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Clinical Biomarkers Market Size YoY Growth 2017-2028 6.4.2 Latin America Clinical Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Clinical Biomarkers Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Clinical Biomarkers Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Company Details 7.1.2 Abbott Laboratories Business Overview 7.1.3 Abbott Laboratories Clinical Biomarkers Introduction 7.1.4 Abbott Laboratories Revenue in Clinical Biomarkers Business (2017-2022) 7.1.5 Abbott Laboratories Recent Development 7.2 Agilent Technologies, Inc. 7.2.1 Agilent Technologies, Inc. Company Details 7.2.2 Agilent Technologies, Inc. Business Overview 7.2.3 Agilent Technologies, Inc. Clinical Biomarkers Introduction 7.2.4 Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2017-2022) 7.2.5 Agilent Technologies, Inc. Recent Development 7.3 ALCEDIAG 7.3.1 ALCEDIAG Company Details 7.3.2 ALCEDIAG Business Overview 7.3.3 ALCEDIAG Clinical Biomarkers Introduction 7.3.4 ALCEDIAG Revenue in Clinical Biomarkers Business (2017-2022) 7.3.5 ALCEDIAG Recent Development 7.4 Becton, Dickinson and Company 7.4.1 Becton, Dickinson and Company Company Details 7.4.2 Becton, Dickinson and Company Business Overview 7.4.3 Becton, Dickinson and Company Clinical Biomarkers Introduction 7.4.4 Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2017-2022) 7.4.5 Becton, Dickinson and Company Recent Development 7.5 bioMérieux S.A. 7.5.1 bioMérieux S.A. Company Details 7.5.2 bioMérieux S.A. Business Overview 7.5.3 bioMérieux S.A. Clinical Biomarkers Introduction 7.5.4 bioMérieux S.A. Revenue in Clinical Biomarkers Business (2017-2022) 7.5.5 bioMérieux S.A. Recent Development 7.6 Bio-Rad Laboratories, Inc. 7.6.1 Bio-Rad Laboratories, Inc. Company Details 7.6.2 Bio-Rad Laboratories, Inc. Business Overview 7.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Introduction 7.6.4 Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2017-2022) 7.6.5 Bio-Rad Laboratories, Inc. Recent Development 7.7 CENTOGENE N.V. 7.7.1 CENTOGENE N.V. Company Details 7.7.2 CENTOGENE N.V. Business Overview 7.7.3 CENTOGENE N.V. Clinical Biomarkers Introduction 7.7.4 CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2017-2022) 7.7.5 CENTOGENE N.V. Recent Development 7.8 F. Hoffmann-La Roche Ltd. 7.8.1 F. Hoffmann-La Roche Ltd. Company Details 7.8.2 F. Hoffmann-La Roche Ltd. Business Overview 7.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Introduction 7.8.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2017-2022) 7.8.5 F. Hoffmann-La Roche Ltd. Recent Development 7.9 Enzo Biochem Inc. 7.9.1 Enzo Biochem Inc. Company Details 7.9.2 Enzo Biochem Inc. Business Overview 7.9.3 Enzo Biochem Inc. Clinical Biomarkers Introduction 7.9.4 Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2017-2022) 7.9.5 Enzo Biochem Inc. Recent Development 7.10 Illumina, Inc. 7.10.1 Illumina, Inc. Company Details 7.10.2 Illumina, Inc. Business Overview 7.10.3 Illumina, Inc. Clinical Biomarkers Introduction 7.10.4 Illumina, Inc. Revenue in Clinical Biomarkers Business (2017-2022) 7.10.5 Illumina, Inc. Recent Development 7.11 Myriad Genetics, Inc. 7.11.1 Myriad Genetics, Inc. Company Details 7.11.2 Myriad Genetics, Inc. Business Overview 7.11.3 Myriad Genetics, Inc. Clinical Biomarkers Introduction 7.11.4 Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2017-2022) 7.11.5 Myriad Genetics, Inc. Recent Development 7.12 Quest Diagnostics Incorporated 7.12.1 Quest Diagnostics Incorporated Company Details 7.12.2 Quest Diagnostics Incorporated Business Overview 7.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Introduction 7.12.4 Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2017-2022) 7.12.5 Quest Diagnostics Incorporated Recent Development 7.13 QIAGEN N.V. 7.13.1 QIAGEN N.V. Company Details 7.13.2 QIAGEN N.V. Business Overview 7.13.3 QIAGEN N.V. Clinical Biomarkers Introduction 7.13.4 QIAGEN N.V. Revenue in Clinical Biomarkers Business (2017-2022) 7.13.5 QIAGEN N.V. Recent Development 7.14 Thermo Fisher Scientific Inc. 7.14.1 Thermo Fisher Scientific Inc. Company Details 7.14.2 Thermo Fisher Scientific Inc. Business Overview 7.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Introduction 7.14.4 Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2017-2022) 7.14.5 Thermo Fisher Scientific Inc. Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Clinical Biomarkers Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Clinical Biomarkers Market Trends Table 3. Clinical Biomarkers Market Drivers Table 4. Clinical Biomarkers Market Challenges Table 5. Clinical Biomarkers Market Restraints Table 6. Global Clinical Biomarkers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Clinical Biomarkers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Clinical Biomarkers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Clinical Biomarkers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Clinical Biomarkers Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Clinical Biomarkers Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Clinical Biomarkers Revenue Share by Player, 2017-2022 Table 13. Global Clinical Biomarkers Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Clinical Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarkers as of 2021) Table 15. Top Players of Clinical Biomarkers in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Clinical Biomarkers Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Clinical Biomarkers Players in United States Market, Ranking by Revenue (2021) Table 20. United States Clinical Biomarkers Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Clinical Biomarkers Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Clinical Biomarkers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Clinical Biomarkers Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Clinical Biomarkers Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Clinical Biomarkers Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Clinical Biomarkers Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Clinical Biomarkers Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Clinical Biomarkers Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Clinical Biomarkers Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Abbott Laboratories Company Details Table 31. Abbott Laboratories Business Overview Table 32. Abbott Laboratories Clinical Biomarkers Product Table 33. Abbott Laboratories Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 34. Abbott Laboratories Recent Development Table 35. Agilent Technologies, Inc. Company Details Table 36. Agilent Technologies, Inc. Business Overview Table 37. Agilent Technologies, Inc. Clinical Biomarkers Product Table 38. Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 39. Agilent Technologies, Inc. Recent Development Table 40. ALCEDIAG Company Details Table 41. ALCEDIAG Business Overview Table 42. ALCEDIAG Clinical Biomarkers Product Table 43. ALCEDIAG Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 44. ALCEDIAG Recent Development Table 45. Becton, Dickinson and Company Company Details Table 46. Becton, Dickinson and Company Business Overview Table 47. Becton, Dickinson and Company Clinical Biomarkers Product Table 48. Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 49. Becton, Dickinson and Company Recent Development Table 50. bioMérieux S.A. Company Details Table 51. bioMérieux S.A. Business Overview Table 52. bioMérieux S.A. Clinical Biomarkers Product Table 53. bioMérieux S.A. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 54. bioMérieux S.A. Recent Development Table 55. Bio-Rad Laboratories, Inc. Company Details Table 56. Bio-Rad Laboratories, Inc. Business Overview Table 57. Bio-Rad Laboratories, Inc. Clinical Biomarkers Product Table 58. Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 59. Bio-Rad Laboratories, Inc. Recent Development Table 60. CENTOGENE N.V. Company Details Table 61. CENTOGENE N.V. Business Overview Table 62. CENTOGENE N.V. Clinical Biomarkers Product Table 63. CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 64. CENTOGENE N.V. Recent Development Table 65. F. Hoffmann-La Roche Ltd. Company Details Table 66. F. Hoffmann-La Roche Ltd. Business Overview Table 67. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Product Table 68. F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 69. F. Hoffmann-La Roche Ltd. Recent Development Table 70. Enzo Biochem Inc. Company Details Table 71. Enzo Biochem Inc. Business Overview Table 72. Enzo Biochem Inc. Clinical Biomarkers Product Table 73. Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 74. Enzo Biochem Inc. Recent Development Table 75. Illumina, Inc. Company Details Table 76. Illumina, Inc. Business Overview Table 77. Illumina, Inc. Clinical Biomarkers Product Table 78. Illumina, Inc. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 79. Illumina, Inc. Recent Development Table 80. Myriad Genetics, Inc. Company Details Table 81. Myriad Genetics, Inc. Business Overview Table 82. Myriad Genetics, Inc. Clinical Biomarkers Product Table 83. Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 84. Myriad Genetics, Inc. Recent Development Table 85. Quest Diagnostics Incorporated Company Details Table 86. Quest Diagnostics Incorporated Business Overview Table 87. Quest Diagnostics Incorporated Clinical Biomarkers Product Table 88. Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 89. Quest Diagnostics Incorporated Recent Development Table 90. QIAGEN N.V. Company Details Table 91. QIAGEN N.V. Business Overview Table 92. QIAGEN N.V. Clinical Biomarkers Product Table 93. QIAGEN N.V. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 94. QIAGEN N.V. Recent Development Table 95. Thermo Fisher Scientific Inc. Company Details Table 96. Thermo Fisher Scientific Inc. Business Overview Table 97. Thermo Fisher Scientific Inc. Clinical Biomarkers Product Table 98. Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2017-2022) & (US$ Million) Table 99. Thermo Fisher Scientific Inc. Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Clinical Biomarkers Product Picture Figure 2. Global Clinical Biomarkers Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Clinical Biomarkers Market Size 2017-2028 (US$ Million) Figure 4. United States Clinical Biomarkers Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Clinical Biomarkers Market Size 2017-2028 (US$ Million) Figure 6. United States Clinical Biomarkers Market Share in Global 2017-2028 Figure 7. Clinical Biomarkers Report Years Considered Figure 8. Product Picture of Diagnostic Biomarkers Figure 9. Product Picture of Predictive Biomarkers Figure 10. Product Picture of Prognostic Biomarkers Figure 11. Global Clinical Biomarkers Market Share by Type in 2022 & 2028 Figure 12. Global Clinical Biomarkers Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Clinical Biomarkers Market Share by Type (2017-2028) Figure 14. United States Clinical Biomarkers Market Share by Type in 2022 & 2028 Figure 15. United States Clinical Biomarkers Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Clinical Biomarkers Market Share by Type (2017-2028) Figure 17. Product Picture of Research and Academic Laboratories Figure 18. Product Picture of Biopharmaceutical and Biotech Companies Figure 19. Product Picture of Diagnostic Centers Figure 20. Product Picture of Others Figure 21. Global Clinical Biomarkers Market Share by Application in 2022 & 2028 Figure 22. Global Clinical Biomarkers Market Size by Application (2017-2028) & (US$ Million) Figure 23. Global Clinical Biomarkers Market Share by Application (2017-2028) Figure 24. United States Clinical Biomarkers Market Share by Application in 2022 & 2028 Figure 25. United States Clinical Biomarkers Market Size by Application (2017-2028) & (US$ Million) Figure 26. United States Clinical Biomarkers Market Share by Application (2017-2028) Figure 27. North America Clinical Biomarkers Market Size Growth Rate 2017-2028 (US$ Million) Figure 28. United States Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Canada Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Europe Clinical Biomarkers Market Size Growth Rate 2017-2028 (US$ Million) Figure 31. Germany Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. France Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. U.K. Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Italy Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Russia Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Clinical Biomarkers Market Size Growth Rate 2017-2028 (US$ Million) Figure 37. China Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Japan Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. South Korea Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. India Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Australia Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. China Taiwan Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Indonesia Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Thailand Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Malaysia Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Clinical Biomarkers Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Clinical Biomarkers Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. UAE Clinical Biomarkers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Abbott Laboratories Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 55. Agilent Technologies, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 56. ALCEDIAG Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 57. Becton, Dickinson and Company Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 58. bioMérieux S.A. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 59. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 60. CENTOGENE N.V. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 62. Enzo Biochem Inc. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 63. Illumina, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 64. Myriad Genetics, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 65. Quest Diagnostics Incorporated Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 66. QIAGEN N.V. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 67. Thermo Fisher Scientific Inc. Revenue Growth Rate in Clinical Biomarkers Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed
Abbott Laboratories Agilent Technologies, Inc. ALCEDIAG Becton, Dickinson and Company bioMérieux S.A. Bio-Rad Laboratories, Inc. CENTOGENE N.V. F. Hoffmann-La Roche Ltd. Enzo Biochem Inc. Illumina, Inc. Myriad Genetics, Inc. Quest Diagnostics Incorporated QIAGEN N.V. Thermo Fisher Scientific Inc.
  • PRICE
  • $4350
    $8700
    $5075

Our Clients